Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,431
Sort by:
2018 POC Hematology and Flow Cytometry Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities
US$ 5,500.00
... contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory ... effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market. Rationale The growing economic pressures on ...
June 2018
238 pages
2018 POC Infectious Disease Testing Market: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
US$ 5,500.00
... 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements ... business, R&D and marketing strategies for the global POC infectious disease testing market. Rationale The growing economic pressures on hospitals, ...
June 2018
795 pages
2018 PT and APTT Point-of-Care Testing Market: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
US$ 2,900.00
... VPGMarketResearch contains 31 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory ... Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers Sales and ...
June 2018
337 pages
2018 Europe Cell Surface Testing Market: Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
US$ 3,850.00
... supplier shares) $2,500. The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts ... a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current ...
June 2018
125 pages
2018 Cell Surface Testing Market: Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
US$ 5,350.00
... report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) ... characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies ...
June 2018
120 pages
Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast
US$ 1,290.00
... cancer test market in the developing countries. Renub Research report titled “Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast” provides a complete analysis of Asia Cervical Cancer ...
June 2018
Europe Cervical Cancer Diagnostic Market & Forecast, By Test Type (Pap smear and HPV DNA), Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway and Netherlands)
US$ 1,290.00
... Cancer Diagnostic Market & Forecast, By Test Type (Pap smear and HPV DNA), Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway and Netherlands)” provides a complete analysis of Europe Cervical Cancer Screening Market. The covers European Countries Cervical Cancer Test Market ...
June 2018
2018 POC Lipid Testing Market: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
US$ 4,350.00
... contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, ... suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market. Rationale The growing economic pressures on ...
June 2018
340 pages
2018 Europe Hematology and Flow Cytometry Market: France, Germany, Italy, Spain, UK--Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities for Suppliers
US$ 19,700.00
... systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody ... Current and Emerging Products- Analysis of current and emerging hematology and flow cytometry tests - Reagent and instrument sales forecasts by market ...
June 2018
450 pages
2018 Europe Infectious Disease Testing Market: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 19,700.00
... needs.- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and ... applications for infectious disease testing.- Global listings of companies developing or marketing infectious disease diagnostic products by individual test. Competitive Assessments ...
June 2018
1600 pages
2018 Europe Cancer Diagnostics Market: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 19,700.00
... suggests alternative business expansion strategies for suppliers.strong> RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
June 2018
820 pages
Liver Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Targeted Therapy, Immunotherapy), By Country (U.S., Japan, U.K., Germany, Spain, Italy, France), And Segment Forecasts, 2016 - 2022
US$ 5,950.00
The global liver cancer drugs market size is expected to be valued at USD 1.47 billion by 2022, as per a new report by Grand ... of 19.4% during the forecast period. The growth of liver cancer market is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rising public ...
June 2018
92 pages
Colorectal Cancer (CRC) Drugs/ Therapeutic Market Size, Share & Trends Analysis Report by Drug Class (Chemotherapy, Immunotherapy), By Country (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 - 2022
US$ 5,950.00
The global colorectal cancer (CRC) drugs market size is expected to reach ... some of the unmet needs of the colorectal cancer (CRC) market. If approved, Array Biopharma’s ... drugs Roche led the colorectal cancer industrial setting in 2016 due to growing usage of Avastin. Avastin was the highest revenue-generating CRC ...
June 2018
99 pages
